Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Gilead Sciences Inc GILD

Healthcare Biotechnology
Gilead Sciences, Inc. is a biopharmaceutical company. The Company is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, COVID-19, cancer and inflammation. It is focused on discovering, developing and delivering medicines to address unmet medical needs in virology, oncology and other therapeutic areas. Its... see more

Recent & Breaking News (NDAQ:GILD)

Nutrition - Pharma Stocks in the News: Embark Holdings, GNC, Vitamin Shoppe, Gilead Sciences, Pfizer

PR Newswire June 26, 2013

North American Life Science Sector Wraps Up Construction on 69 Projects Topping $3 Billion in Second-Quarter 2013, an Industrial Info News Alert

Marketwired June 25, 2013

Secrets to Making Money in PG, MRK, GILD and F

Marketwired June 18, 2013

Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics

PR Newswire June 18, 2013

Gilead Sciences to Present at the Wells Fargo Securities 2013 Healthcare Conference on Tuesday, June 18

Business Wire June 17, 2013

Gilead Announces Interim Phase 2 Data for Idelalisib Showing Response in Refractory Indolent Non-Hodgkin's Lymphoma

Business Wire June 17, 2013

The Straight Truth, Investing in FITB, HTZ, BRCM and GILD

Marketwired June 13, 2013

Profitable Trading Secrets Revealed in SFD, GILD, CMCSA and ARR

Marketwired June 11, 2013

Gilead Sciences to Present at the Goldman Sachs 34th Annual Healthcare Conference on Tuesday, June 11

Business Wire June 10, 2013

Key to Success, How to Profit: GILD and ITUB

Marketwired June 10, 2013

Gilead Announces U.S. FDA Priority Review Designation for Sofosbuvir for the Treatment of Hepatitis C

Business Wire June 7, 2013

Companies Taking Strategic Initiatives in Delivering Innovative Solutions to Boost Sales and Meet Customer Demands - Research Report on ResMed, Quest Diagnostics, Mettler-Toledo, Gilead, and TearLab

PR Newswire June 7, 2013

Special Situation Coming Soon, a Look Inside GILD, HL and AA

Marketwired June 7, 2013

The Real Story Behind KNDI, NWSA, GILD and CRM

Marketwired June 6, 2013

Before the Crowd, How We Found GILD, GLW, SPLS and TSM

Marketwired June 5, 2013

Regulatory Wins, Leadership Changes, and New Partnerships Creating Healthy Prospects - Research Report on Gilead, Biogen Idec, GlaxoSmithKline, Viropharma, and Celsion

PR Newswire May 31, 2013

Pre-Market Analysis on GILD, NPSP, HALO, SNTS, and ITMN

ACCESS Newswire May 30, 2013

Gilead Sciences to Present at the Deutsche Bank 38th Annual Health Care Conference on Wednesday, May 29

Business Wire May 28, 2013

European Commission Approves Stribild®, a New Single Tablet Regimen for the Treatment of HIV-1 Infection

Business Wire May 28, 2013

Perfect Trade Setups, How to Play GILD, CPST, BMC and INFN

Marketwired May 25, 2013